BioDelivery Sciences International to Present at Wall Street Analyst Forum.MORRISVILLE, N.C. -- BioDelivery Sciences International, Inc.(NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : BDSI) announced today that its President and Chief Executive Officer, Mark A. Sirgo, Pharm.D., and the company's Chief Financial Officer, James A. McNulty Most Rev. James A. McNulty (died September 4, 1972) was the 10th Bishop of Buffalo, New York. Preceded by Joseph A. Burke Bishop of Buffalo 1963–1972 Succeeded by Edward D. Head , CPA (Computer Press Association, Landing, NJ) An earlier membership organization founded in 1983 that promoted excellence in computer journalism. Its annual awards honored outstanding examples in print, broadcast and electronic media. The CPA disbanded in 2000. , are scheduled to present at the upcoming Wall Street Analyst Forum at the Roosevelt Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. on November 29, 2005. Dr. Sirgo and Mr. McNulty will be discussing BDSI's financial history, product pipeline, served markets and growth strategy for the upcoming year at 1:20 pm. BDSI's presentation will also be available via live webcast and archived for up to 30 days on Vcall. The Wall Street Analyst Forum has organized 75 major analyst conferences for NYSE NYSE See: New York Stock Exchange , NASDAQ and AMEX AMEX See: American Stock Exchange corporations in New York, Boston and London. Large-cap, mid-cap and small-cap corporations have chosen to present at the various Forums once a year based on the comprehensiveness of the conferences to the buy/sell-side. The Forum runs through Thursday, December 1, 2005. BioDelivery Sciences International, Inc. is a specialty biopharmaceutical company that is exploiting its licensed and patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties, clinically-significant new formulations of proven therapeutics targeted at "acute" treatment opportunities such as pain, anxiety, nausea and vomiting Nausea and Vomiting Definition Nausea is the sensation of being about to vomit. Vomiting, or emesis, is the expelling of undigested food through the mouth. and infections. The company's drug delivery technologies include: (i) the patented Bioral(R) nanocochleate technology, designed for a potentially broad base of applications, and (ii) the patented BEMA(TM) (transmucosal or mouth) drug delivery technology. The company's headquarters are located in Morrisville, North Carolina Morrisville is a town in Wake County, North Carolina, USA. The population was 5,208 at the 2000 census. A Special Census was conducted by the United States Census Bureau in March 2004, when the population was enumerated at 11,915. and its principal laboratory is located in Newark, New Jersey. Note: Except for the historical information contained herein, this press release contains forward-looking statements that involve risks and uncertainties. Such statements are subject to certain factors, which may cause the Company's results to differ. Factors that may cause such differences include, but are not limited to, the Company's ability to accurately forecast the demand for each of its or Arius Pharmaceuticals, Inc.'s licensed technologies and products associated therewith, the gross margins achieved from the sale of those products and the expenses and other cash needs for the upcoming periods. The Company's ability to obtain raw materials form its contract manufacturers on a timely basis, if at all, the Company's need for additional funding, uncertainties regarding the Company's intellectual property and other research, development, marketing and regulatory risks and certain other factors that may affect future operating results and are detailed in the company's filings with the Securities and Exchange Commission. L.G. Zangani, LLC provides financial public relations Financial public relations Public relations division of a company charged with cultivating positive investor relations and proper disclosure information. service to the Company. As such L.G. Zangani, LLC and/or its officers, agents and employees receives remuneration for public relations and/or other services in the form of monies, capital stock in the Company, warrants or options to purchase capital in the Company. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion